1997
DOI: 10.1271/bbb.61.1949
|View full text |Cite
|
Sign up to set email alerts
|

Human Placental Fructose-6-phosphate,2-kinase/Fructose-2,6-bisphosphatase: Its Isozymic Form, Expression and Characterization

Abstract: The nucleotide sequence of 1981 bp cDNA containing the entire coding region of a human placental fructose-6-phosphate,2-kinase/fructose-2,6-bisphosphatase was determined. The sequence encodes 469 amino acids and, based on homology to the rat testis enzyme, appears to be the testis-type isozyme expressed in placenta. The enzyme was expressed in Escherichia coli BL21 (DE3) by using a T7 RNA polymerase-based expression system and purified to homogeneity. The expressed enzyme was bifunctional with specific activit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
12
0

Year Published

1998
1998
2018
2018

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 0 publications
0
12
0
Order By: Relevance
“…It was nearly a century ago when Warburg described that cancer cells show characteristic metabolic alterations which make them highly dependent on glycolysis for survival and spreading . PFKFB3 gene is overexpressed in tumours and codes for the PFKFB3 isoenzyme of PFK‐2/FBPase‐2, which has the highest kinase/bisphosphatase ratio and maintains a high Fru‐2,6‐P 2 concentration in tumour cells . The inhibition of PFKFB3 causes a glycolytic blockage that results in impaired vessel sprouting , cell cycle arrest and cell death, and reduction of anchorage‐independent growth of tumour cell colonies and animal tumour burden .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It was nearly a century ago when Warburg described that cancer cells show characteristic metabolic alterations which make them highly dependent on glycolysis for survival and spreading . PFKFB3 gene is overexpressed in tumours and codes for the PFKFB3 isoenzyme of PFK‐2/FBPase‐2, which has the highest kinase/bisphosphatase ratio and maintains a high Fru‐2,6‐P 2 concentration in tumour cells . The inhibition of PFKFB3 causes a glycolytic blockage that results in impaired vessel sprouting , cell cycle arrest and cell death, and reduction of anchorage‐independent growth of tumour cell colonies and animal tumour burden .…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, tissue‐specific isoenzymes are not totally exclusive and cells and tissues can express more than one to respond to different physiological conditions or stimuli . The PFKFB3 isoenzyme has a high kinase/bisphosphatase activity ratio, which makes it a net producer of Fru‐2,6‐P 2 , and it is overexpressed in proliferative cells and tumours . PFKFB3 suppression decreases Fru‐2,6‐P 2 and lactate production, apoptosis, inhibition of anchorage‐independent colony formation and impaired vessel sprouting and tumour growth .…”
mentioning
confidence: 99%
“…PFKFB4 is a bifunctional enzyme comprising kinase as well as phosphatase activity, with the latter being slightly stronger (Sakakibara et al, 1997). It regulates the steady-state concentration of fructose 2,6-bisphosphate which is an activator of PFK-1 and therefore of glycolysis.…”
Section: Discussionmentioning
confidence: 99%
“…The conversion of fructose 6-phosphate to fructose 1,6-bisphosphate by 6-phosphofructokinase-1 (PFK-1) is a critical step for a high glycolytic rate. The PFKFB3 isoenzyme has the highest kinase/ bisphosphatase activity ratio, favoring net synthesis of Fru-2,6-P 2 [29]. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB) [EC:2.7.1.105/EC:3.1.3.46] catalyzes both the synthesis and degradation of Fru-2,6-P 2 .…”
Section: Introductionmentioning
confidence: 99%